The half-life of  131 I-insulin in different groups of patients compared with normal subjects.
D001797:Blood Protein Electrophoresis; D002352:Carrier Proteins; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D007456:Iodine Isotopes; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D011863:Radioimmunoassay; D014915:Whole-Body Counting
D002352:Carrier Proteins; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D007456:Iodine Isotopes